Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IMNN
IMNN | US
2.14
USD-0.01
-0.47%
IMNN | US
About IMNN
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
02/06/2026
Close
2.14
Open
2.15
High
2.18
Low
2.06
Imunon Inc. a clinical stage biotechnology company engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The Company's lead clinical programs comprise IMNN-001 a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development; and ThermoDox for the treatment of hepatocellular carcinoma. It also has two platform technologies such as TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies; and PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The company was formerly known as Celsion Corporation and changed its name to Imunon Inc. in September 2022. Imunon Inc. was founded in 1982 and is based in Lawrenceville New Jersey.
View LessIMNN | US
Risk
45.2
Sharpe
-1.19
Luna's Score
40/100
Recommendation
Sell
Luna says (IMNN | US)
What's Working
Low Debt to Asset (< 0.2)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
46.0%1 month
45.2%3 months
47.8%6 months
54.4%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
3.79
Debt to equity
0.37
Debt to assets
0.14
Ent. to EBITDA
0.91
Ent. to rev.
4.00
PEG
-
Other Fundamentals
EBITDA
-19.62M
MarketCap
30.82M
MarketCap(USD)
30.82M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-143.19
Short ratio
1.64
Short perc.
3.01
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.44
Range1M
0.89
Range3M
1.53
Volumes: Market Activity
Rel. volume
0.94
Price X volume
108.52K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.91 | - | Expensive |
| Ent. to Revenue | 4.00 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 3.79 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 47.77 | - | Lower Risk |
| Debt to Equity | 0.37 | -1.23 | Expensive |
| Debt to Assets | 0.14 | 0.25 | Cheaper |
| Market Cap | 30.82M | - | Emerging |
